Insider Selling: Zeltiq Aesthetics Inc. (ZLTQ) Insider Sells 8,000 Shares of Stock
Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) insider Keith J. Sullivan sold 8,000 shares of the business’s stock in a transaction dated Tuesday, October 4th. The stock was sold at an average price of $38.84, for a total value of $310,720.00. Following the sale, the insider now owns 82,591 shares in the company, valued at approximately $3,207,834.44. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.
Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) opened at 40.51 on Friday. The company has a 50-day moving average price of $38.66 and a 200-day moving average price of $31.77. Zeltiq Aesthetics Inc. has a 12-month low of $18.41 and a 12-month high of $41.43. The firm has a market cap of $1.61 billion, a P/E ratio of 60.92 and a beta of 0.79.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last posted its quarterly earnings results on Monday, August 8th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.07. The firm earned $89.50 million during the quarter, compared to the consensus estimate of $79.68 million. Zeltiq Aesthetics had a net margin of 9.54% and a negative return on equity of 9.90%. Zeltiq Aesthetics’s revenue was up 38.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.03 EPS. On average, analysts predict that Zeltiq Aesthetics Inc. will post ($0.13) earnings per share for the current year.
A number of institutional investors have recently bought and sold shares of the stock. FMR LLC boosted its position in Zeltiq Aesthetics by 45.2% in the second quarter. FMR LLC now owns 4,277,811 shares of the company’s stock valued at $116,913,000 after buying an additional 1,332,129 shares in the last quarter. BlackRock Fund Advisors boosted its position in shares of Zeltiq Aesthetics by 134.5% in the first quarter. BlackRock Fund Advisors now owns 2,098,036 shares of the company’s stock worth $56,983,000 after buying an additional 1,203,254 shares during the period. Alliancebernstein L.P. boosted its position in shares of Zeltiq Aesthetics by 2,184.0% in the second quarter. Alliancebernstein L.P. now owns 1,164,819 shares of the company’s stock worth $31,835,000 after buying an additional 1,113,819 shares during the period. Deerfield Management Co. bought a new position in shares of Zeltiq Aesthetics during the first quarter worth about $29,996,000. Finally, Samlyn Capital LLC bought a new position in shares of Zeltiq Aesthetics during the first quarter worth about $29,100,000.
Several analysts have issued reports on ZLTQ shares. TheStreet downgraded Zeltiq Aesthetics from a “buy” rating to a “hold” rating in a report on Friday, June 10th. Brean Capital restated a “buy” rating and set a $35.00 price objective on shares of Zeltiq Aesthetics in a report on Tuesday, June 21st. Leerink Swann restated a “buy” rating on shares of Zeltiq Aesthetics in a report on Thursday, June 30th. Zacks Investment Research downgraded Zeltiq Aesthetics from a “hold” rating to a “sell” rating in a report on Thursday, July 14th. Finally, Maxim Group upped their target price on Zeltiq Aesthetics from $40.00 to $48.00 and gave the company a “buy” rating in a report on Tuesday, August 9th. Three analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $39.89.
Zeltiq Aesthetics Company Profile
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
Receive News & Stock Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related stocks with our FREE daily email newsletter.